Cite
HARVARD Citation
Toyoda, H. et al. (2017). Liver Fibrosis Indices for Identifying Patients at Low Risk of Developing Hepatocellular Carcinoma after Eradication of HCV. Antiviral therapy. 22 (3), pp. 185-193. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Toyoda, H. et al. (2017). Liver Fibrosis Indices for Identifying Patients at Low Risk of Developing Hepatocellular Carcinoma after Eradication of HCV. Antiviral therapy. 22 (3), pp. 185-193. [Online].